Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
5 pending office actions • 4 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Kindeva Drug Delivery L.P. is currently managing 7 pending office actions within the Biotechnology & Pharmaceuticals technology area. These actions are distributed among 6 distinct examiners, indicating that most matters are being reviewed by different officials. The workload is spread across 5 distinct art units, which reflects a diverse range of pharmaceutical or drug delivery technologies under review. This distribution across multiple units suggests a broad research and development focus within the biotechnology sector.
The busiest examiner, HAGHIGHATIAN, MINA, is responsible for 2 pending office actions. This is the only examiner in the current portfolio managing more than one pending matter, as the remaining 5 actions are split among 5 other examiners. With 2 busiest examiner pending actions, this specific official holds a significant portion of the company's active prosecution. Practitioners should prioritize monitoring this examiner's specific requirements and historical allowance rates to effectively manage the 7 total pending actions. Coordinating arguments across 5 art units requires a robust strategy to maintain consistency while addressing the unique technical demands of each examiner.
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (20%) |
| Double-patenting + other | 1 (20%) |
| Multi-statute (no §101) | 3 (60%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CHANG, THOMAS ZHU | 1 | 52.2% | +66.9% |
| MOK, ANDREW JUN-WAI | 1 | 53.3% | +65.4% |
| WOODWARD, VALERIE LYNN | 1 | 71.3% | +27.1% |
| HAGHIGHATIAN, MINA | 1 | 46.0% | +39.4% |
| GHALI, ISIS A D | 1 | 27.9% | +41.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17921774 | ADHESIVE ARTICLE AND METHOD OF MAKING SAME | MOK, ANDREW JUN-WAI | 49d overdue |
| 17802431 | INHALER | WOODWARD, VALERIE LYNN | 27d |
| 17612132 | Removable Film-Forming Gel Compositions Featuring Adhesion Promoters | GHALI, ISIS A D | 50d |
| 18694108 | INHALER AUTHORISATION APPARATUS AND AN INHALER INCLUDING SUCH AN APPARATUS | CHANG, THOMAS ZHU | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17921774 | ADHESIVE ARTICLE AND METHOD OF MAKING SAME | MOK, ANDREW JUN-WAI | 49d overdue |
| 17802431 | INHALER | WOODWARD, VALERIE LYNN | 27d |
| 17612132 | Removable Film-Forming Gel Compositions Featuring Adhesion Promoters | GHALI, ISIS A D | 50d |
| 18694108 | INHALER AUTHORISATION APPARATUS AND AN INHALER INCLUDING SUCH AN APPARATUS | CHANG, THOMAS ZHU | — |
| 17620325 | AEROSOL FORMULATION, CANISTER, AND INHALER CONTAINING THE FORMULATION, AND METHOD OF USE | HAGHIGHATIAN, MINA | — |
| Art Unit | Apps |
|---|---|
| 3785 | 2 |
| 3786 | 1 |
| 1616 | 1 |
| 1611 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18694108 | INHALER AUTHORISATION APPARATUS AND AN INHALER INCLUDING SUCH AN APPARATUS | CHANG, THOMAS ZHU | 3785 | §102§103§112 | Non-Final OA | — | Pending | Mar 21, 2024 |
| 17921774 | ADHESIVE ARTICLE AND METHOD OF MAKING SAME | MOK, ANDREW JUN-WAI | 3786 | §102§103§112 | Non-Final OA | 49d overdue | Pending | Oct 27, 2022 |
| 17802431 | INHALER | WOODWARD, VALERIE LYNN | 3785 | §103§112 | Final Rejection | 27d | Pending | Aug 25, 2022 |
| 17620325 | AEROSOL FORMULATION, CANISTER, AND INHALER CONTAINING THE FORMULATION, AND METHOD OF USE | HAGHIGHATIAN, MINA | 1616 | §103§112DP | Non-Final OA | — | Pending | Dec 17, 2021 |
| 17612132 | Removable Film-Forming Gel Compositions Featuring Adhesion Promoters | GHALI, ISIS A D | 1611 | §103Other | Non-Final OA | 50d | Pending | Nov 17, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialKindeva Drug Delivery L.P. has 5 pending office actions as of October 2026, spread across 4 art units and 5 examiners.
Thomas Zhu Chang has the most, with 1 of Kindeva Drug Delivery L.P.'s pending office actions.
Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.
